MAF1 and Alzheimer disease: In conclusion, our study demonstrates the critical role of the Maf1-NMDAR1 signalling pathway in synaptic and calcium dysfunction in early AD, suggesting that Maf1 may be a potential therapeutic intervention target for early AD.